Publications in collaboration with researchers from University of Pavia (1)

2021

  1. DUART: Durvalumab after radiotherapy in patients with unresectable, stage III NSCLC who are ineligible for chemotherapy

    Future Oncology, Vol. 17, Núm. 34, pp. 4657-4663